Immunotech Laboratories, Inc. Stock
Stocks
IMMB
US45254F2039
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000200 USD | -.--% |
|
-.--% | +100.00% |
| Market Cap | 6.06M 5.31M 4.9M 4.53M 8.59M 580M 8.76M 58.95M 22.9M 284M 22.74M 22.24M 985M | P/E 2008 * |
-
| P/E 2009 | -310x |
|---|---|---|---|---|---|
| Enterprise Value | 7.25M 6.36M 5.87M 5.42M 10.28M 694M 10.48M 70.54M 27.41M 340M 27.21M 26.62M 1.18B | EV / Sales 2008 * |
-
| EV / Sales 2009 | - |
| Free-Float |
99.34% | Yield 2008 * |
-
| Yield 2009 | - |
| 6 months | +100.00% | ||
| Current year | +100.00% |
| 1 month | 0 |  | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0 |
| 5 years | 0 | | 0.01 |
| 10 years | 0 | | 0.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
Harry Zhabilov
PSD | President | 59 | 2009-12-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Harry Zhabilov
CHM | Chairman | 59 | 2014-06-30 |
| Director/Board Member | 61 | 2013-02-03 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | +100.00% | -60.00% | 115K | |
| -1.53% | +0.78% | +72.33% | +129.70% | 57.72B | |
| -2.45% | -7.83% | +63.92% | +83.15% | 52.65B | |
| +3.27% | +8.91% | +21.21% | +486.76% | 24.46B | |
| -0.81% | -0.42% | -16.24% | -12.47% | 23.84B | |
| +4.82% | +4.24% | +44.32% | -1.63% | 19.28B | |
| -0.24% | +5.11% | +38.76% | -26.41% | 17.8B | |
| +2.34% | +12.50% | +224.02% | +380.99% | 17.29B | |
| -1.13% | +1.41% | +35.56% | - | 15.28B | |
| -1.70% | +3.98% | +28.96% | +190.57% | 14.35B | |
| Average | +0.26% | +4.96% | +61.29% | +130.07% | 24.27B | |
| Weighted average by Cap. | -0.28% | +3.12% | +57.89% | +142.00% |
| * | 1 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
4
- Stock Market
- Stocks
- IMMB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
